A US oncologist and researcher will tell delegates at the COSA ASM in Melbourne today that medicinal cannabis has a clear role to play in relieving symptoms associated with cancer treatment.
Dr Donald Abrams, Chief of the Hematology – Oncology Division at San Francisco General Hospital, and a Professor of Clinical Medicine at the University of California San Francisco, said he would present evidence from studies demonstrating health benefits, such as stimulating appetite.
“Pre-clinical evidence suggests that cannabis may both prevent and treat chemotherapy-induced peripheral neuropathy,” Dr Abrams said. “New varieties of cannabis and delivery mechanisms are providing promise in terms of minimising adverse effects.”
Dr Abrams said he was glad to be in Australia at a time when the use of medicinal cannabis was being considered.
“The use of cannabis in medicine is often overshadowed by political and law enforcement debates,” he said.
“However, cannabis has a long history of being used for medicinal purposes and should be considered a valid form of symptom relief that we can use to improve cancer patients’ quality of life.”
Watch this space for commentary from Dr Abrams for OncologyNews in the coming days!